[go: up one dir, main page]

RU2006113431A - 2-Ethyl-6-methyl-3-hydroxypyridine n-acetylcysteinate possessing antioxidant, hypoglycemic, hypolipidemic, and anti-shock properties - Google Patents

2-Ethyl-6-methyl-3-hydroxypyridine n-acetylcysteinate possessing antioxidant, hypoglycemic, hypolipidemic, and anti-shock properties Download PDF

Info

Publication number
RU2006113431A
RU2006113431A RU2006113431/15A RU2006113431A RU2006113431A RU 2006113431 A RU2006113431 A RU 2006113431A RU 2006113431/15 A RU2006113431/15 A RU 2006113431/15A RU 2006113431 A RU2006113431 A RU 2006113431A RU 2006113431 A RU2006113431 A RU 2006113431A
Authority
RU
Russia
Prior art keywords
hydroxypyridine
ethyl
methyl
acetylcysteinate
hypolipidemic
Prior art date
Application number
RU2006113431/15A
Other languages
Russian (ru)
Other versions
RU2357955C2 (en
Inventor
Леонид Дмитриевич Смирнов (RU)
Леонид Дмитриевич Смирнов
Вера Ивановна Инчина (RU)
Вера Ивановна Инчина
Ангелина Владимировна Зорькина (RU)
Ангелина Владимировна Зорькина
Original Assignee
Леонид Дмитриевич Смирнов (RU)
Леонид Дмитриевич Смирнов
Вера Ивановна Инчина (RU)
Вера Ивановна Инчина
Ангелина Владимировна Зорькина (RU)
Ангелина Владимировна Зорькина
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Леонид Дмитриевич Смирнов (RU), Леонид Дмитриевич Смирнов, Вера Ивановна Инчина (RU), Вера Ивановна Инчина, Ангелина Владимировна Зорькина (RU), Ангелина Владимировна Зорькина filed Critical Леонид Дмитриевич Смирнов (RU)
Priority to RU2006113431/04A priority Critical patent/RU2357955C2/en
Publication of RU2006113431A publication Critical patent/RU2006113431A/en
Application granted granted Critical
Publication of RU2357955C2 publication Critical patent/RU2357955C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (3)

1. N-ацетилцистеинат 2-этил-6-метил-3-гидроксипиридина, обладающий антиоксидантными, гипогликемическими, гиполипидемическими и противошоковыми свойствами.1. N-acetylcysteinate 2-ethyl-6-methyl-3-hydroxypyridine, which has antioxidant, hypoglycemic, hypolipidemic and anti-shock properties. 2. Способ получения N-ацетилцистеината 2-этил-6-метил-3-гидроксипиридина, который включает взаимодействие эквимолекулярных количеств 2-этил-6-метил-3-гидроксипиридина с N-ацетил-L-цистеином в растворе низшего спирта при перемешивании реагентов и кипячении с последующей отгонкой в вакууме растворителя и перекристаллизации целевого продукта из спирта.2. A method of producing 2-ethyl-6-methyl-3-hydroxypyridine N-acetylcysteinate, which comprises reacting equimolecular amounts of 2-ethyl-6-methyl-3-hydroxypyridine with N-acetyl-L-cysteine in a lower alcohol solution with stirring reagents and boiling, followed by distillation in vacuo of the solvent and recrystallization of the target product from alcohol. 3. Применение N-ацетилцистеината 2-этил-6-метил-3-гидроксипиридина для производства средства для коррекции метаболического синдрома и сосудистых нарушений при сахарном диабете II типа, атеросклерозе и ишемической болезни сердца, а также лечение шоковых состояний при ожоге и других экстремальных воздействиях.3. The use of N-acetylcysteinate 2-ethyl-6-methyl-3-hydroxypyridine for the production of agents for the correction of metabolic syndrome and vascular disorders in type II diabetes mellitus, atherosclerosis and coronary heart disease, as well as the treatment of shock conditions in burns and other extreme conditions .
RU2006113431/04A 2006-04-21 2006-04-21 Antioxidant, antihyperglycemic, hypolipidemic and antishock n-acetylcysteinate 2-ethyl-6-methyl-3-hydroxypyridine RU2357955C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006113431/04A RU2357955C2 (en) 2006-04-21 2006-04-21 Antioxidant, antihyperglycemic, hypolipidemic and antishock n-acetylcysteinate 2-ethyl-6-methyl-3-hydroxypyridine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006113431/04A RU2357955C2 (en) 2006-04-21 2006-04-21 Antioxidant, antihyperglycemic, hypolipidemic and antishock n-acetylcysteinate 2-ethyl-6-methyl-3-hydroxypyridine

Publications (2)

Publication Number Publication Date
RU2006113431A true RU2006113431A (en) 2007-11-10
RU2357955C2 RU2357955C2 (en) 2009-06-10

Family

ID=38957904

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006113431/04A RU2357955C2 (en) 2006-04-21 2006-04-21 Antioxidant, antihyperglycemic, hypolipidemic and antishock n-acetylcysteinate 2-ethyl-6-methyl-3-hydroxypyridine

Country Status (1)

Country Link
RU (1) RU2357955C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2365582C1 (en) * 2008-07-03 2009-08-27 Государственное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарева" Salt of 2-ethyl-6-methyl-3-hydroxypyridine with fumaric acid, possessing metabolic and cardioprotective activity, and method of its obtaining
RU2394816C1 (en) * 2008-11-25 2010-07-20 Виктор Владимирович Яснецов Neurotropic agent with antioxidant, antihypoxic, neuroprotector, antiamnesic and anti-motion sickness activity and capable of enhancing cognitive functions

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2458714C1 (en) * 2011-02-14 2012-08-20 Федеральное Государственное Бюджетное Учреждение Науки Институт Биохимической Физики Им. Н.М. Эмануэля Российской Академии Наук (Ибхф Ран) Antioxidant, photoprotective and geroprotective agent
RU2637168C2 (en) * 2015-03-12 2017-11-30 Закрытое Акционерное Общество "Фармфирма "Сотекс" Pharmaceutical composition in form of solute for intravenous and intramuscular injection and its production process
RU2664453C1 (en) * 2017-11-24 2018-08-17 федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации Derivative of 3-hydroxypyridine with anxiolytic and nootropic effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058145C1 (en) * 1988-12-28 1996-04-20 Центр по химии лекарственных средств Agent showing antishock activity
RU2065299C1 (en) * 1994-07-15 1996-08-20 Акционерное общество закрытого типа "Олвик" Nootropic and tranquilizing agent
RU2145855C1 (en) * 1999-05-26 2000-02-27 Смирнов Леонид Дмитриевич Drug showing anxiolytic, antialcoholic and cerebroprotective effects
RU2210568C1 (en) * 2001-12-14 2003-08-20 Промоненков Виктор Кириллович Method for preparing derivatives of 2-ethyl-6- -methyl-3- hydroxypyridine
RU2284993C2 (en) * 2002-06-14 2006-10-10 Леонид Дмитриевич Смирнов 2-ethyl-6-methyl-3-oxypyrodine salts with organic carboxylic acids possessing anxiolytic, antidepressive, antihypoxic, anti-amnestic and anti-oxidative activity and method for their preparing

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2365582C1 (en) * 2008-07-03 2009-08-27 Государственное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарева" Salt of 2-ethyl-6-methyl-3-hydroxypyridine with fumaric acid, possessing metabolic and cardioprotective activity, and method of its obtaining
RU2394816C1 (en) * 2008-11-25 2010-07-20 Виктор Владимирович Яснецов Neurotropic agent with antioxidant, antihypoxic, neuroprotector, antiamnesic and anti-motion sickness activity and capable of enhancing cognitive functions

Also Published As

Publication number Publication date
RU2357955C2 (en) 2009-06-10

Similar Documents

Publication Publication Date Title
TN2016000558A1 (en) Fatty acids and their use in conjugation to biomolecules
JP2019203015A5 (en)
JP2009506094A5 (en)
US20200199142A1 (en) 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and method for synthesizing optical isomer thereof
CA2534314A1 (en) Benzothiazole derivatives for the treatment of diabetes
HU230609B1 (en) Compounds having hypolipidemic and hypocholesterolemic activities, process for their preparation and pharmaceutical compositions containing them and their use, intermediates
Li et al. Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
CN1119646A (en) Insecticidal tetrahydrofuran-compound
RU2006113431A (en) 2-Ethyl-6-methyl-3-hydroxypyridine n-acetylcysteinate possessing antioxidant, hypoglycemic, hypolipidemic, and anti-shock properties
Lu et al. Rapid syntheses of dehydrodiferulates via biomimetic radical coupling reactions of ethyl ferulate
JP2018502135A5 (en)
JP2016526040A (en) Novel compound derived from Ryukyu genus plant and composition for preventing or treating diabetes containing the same as an active ingredient
NZ610145A (en) Acylbenzene derivative having a hypoglycemic action and/or a β cell- or pancreas-protecting action
US20250136572A1 (en) Para acyl substituted diazacyclohexene derivatives
CA2622452A1 (en) Hemodynamics improving agent
CN102249962B (en) Preparation method of 1,1-disulfur-1-olefin
NO20061599L (en) Benzoxazole acetonitriles
CN1986533A (en) Preparation and application of alkenyl amide cluster compound
KR102014659B1 (en) Pharmaceutical composition for hardening soft tissue
WO2011118625A1 (en) Method for producing optically active n-monoalkyl-3-hydroxy-3-arylpropylamine compound
RU2010128627A (en) 2-Ethyl-6-methyl-3-hydroxypyridine salt with nicotinic acid, possessing hypoglycemic, hypolipidemic and neuroprotective activity, and a method for its preparation
JP2011251952A5 (en)
RU2010148530A (en) 4-Trimethylammoniobutyrates as CPT2 Inhibitors
US20240124399A1 (en) Novel indole derivative, and use thereof for treating diseases related to advanced glycation end products
CN105348276A (en) Synthetic method for 1-{2-floro-4-[5-(4-isobutyl phenyl)-1,2,4-oxadiazol-3-yl]-benzyl}-3-azetidinecarboxylic acid

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160422